Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Postinfectious encephalomyelitis.

Dean M Wingerchuk1

  • 1Department of Neurology, Mayo Clinic, 13400 East Shea Boulevard, Scottsdale, AZ 85259, USA. wingerchuk.dean@mayo.edu

Current Neurology and Neuroscience Reports
|April 15, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Psychiatric comorbidities cluster early after onset in MOGAD: a cross-sectional comparative study with MS and NMOSD.

Journal of neurology, neurosurgery, and psychiatry·2026
Same author

Cerebellar Involvement in Attacks of Aquaporin-4-IgG Positive Neuromyelitis Optica Spectrum Disorder.

Neurology(R) neuroimmunology & neuroinflammation·2024
Same author

Safety and efficacy of inebilizumab for the treatment of neuromyelitis optica spectrum disorder: end-of-study results from the open-label period of the N-MOmentum trial.

The Lancet. Neurology·2024
Same author

MRI of the relevant domain should be performed to confirm whether clinical symptoms represent an attack of NMOSD: Yes.

Multiple sclerosis (Houndmills, Basingstoke, England)·2024
Same author

Alterations in Aquaporin-4-IgG Serostatus in 986 Patients: A Laboratory-Based Longitudinal Analysis.

Annals of neurology·2023
Same author

Attack adjudication in neuromyelitis optica spectrum disorder: Substantiation of criteria by magnetic resonance imaging and biomarkers in N-MOmentum.

Multiple sclerosis (Houndmills, Basingstoke, England)·2023
Same journal

The Noradrenergic Brain in Parkinson's Disease.

Current neurology and neuroscience reports·2026
Same journal

Mapping the Silent Onset of Parkinson's Disease: Monoamine Imaging in the Era of the Race for Preclinical Intervention.

Current neurology and neuroscience reports·2026
Same journal

Functional and Structural Brain Imaging Correlates of Treatment Response in Functional Movement Disorder.

Current neurology and neuroscience reports·2026
Same journal

Astrocytopathy in Wernicke Encephalopathy and Neuromyelitis Optica Spectrum Disorder. Pathogenic Differences With Occasional Clinical and Neuroimaging Overlap. A Review.

Current neurology and neuroscience reports·2026
Same journal

When is the Radiologically Isolated Syndrome already Multiple Sclerosis According to the 2024 McDonald Criteria?

Current neurology and neuroscience reports·2026
Same journal

Assessment and Management of Post-traumatic Headache.

Current neurology and neuroscience reports·2026
See all related articles

Acute disseminated encephalomyelitis (ADEM) is an inflammatory CNS disorder. Recent studies clarify ADEM

Area of Science:

  • Neurology
  • Neuroimmunology
  • Central Nervous System Disorders

Background:

  • Acute disseminated encephalomyelitis (ADEM) is a category of inflammatory demyelinating disorders affecting the central nervous system (CNS).
  • Understanding ADEM is crucial for diagnosing and managing CNS inflammatory conditions.

Purpose of the Study:

  • To review recent findings on the clinical, laboratory, and neuroimaging features of ADEM.
  • To discuss the distinctions between childhood and adult ADEM.
  • To explore the risk of developing multiple sclerosis after ADEM and refine the classification of CNS demyelinating syndromes.

Main Methods:

  • Retrospective analysis of large case series.
  • Review of clinical, laboratory, and neuroimaging data.
  • Synthesis of recent research findings.

Related Experiment Videos

Main Results:

  • Recent case series have enhanced the characterization of ADEM's clinical, laboratory, and neuroimaging profiles.
  • Key differences exist in ADEM presentation between children and adults.
  • The relationship between ADEM and the subsequent risk of multiple sclerosis is being clarified.

Conclusions:

  • Recent research has refined the understanding and classification of ADEM within the spectrum of CNS demyelinating diseases.
  • Distinguishing ADEM from other demyelinating syndromes and assessing long-term risks like multiple sclerosis are critical.
  • Further research contributes to improved diagnostic criteria and management strategies for ADEM.